Reassessment of Theophylline Use for Severe Asthma Exacerbation: Is It Justified in Critically Ill Hospitalized Patients?

REFERENCES

• Expert Panel Report 2. Guidelines for the Diagnosis and Management of Asthma. NIH Publication No. 97-4051, National Institutes of Health, Bethesda 1997
   Google Scholar
• Self T.H., Abou-Shala N., Burns R., Stewart C.F., Ellis R.F., Tsiu S.J., Kellerman A.L. Inhaled Albuterol and Oral Prednisone Therapy in Hospitalized Adult Asthmatics: Does Aminophylline Add Any Benefit?. Chest 1990; 98: 1317–1321
   Google Scholar
• DiGiulio G.A., Kercsmar C.M., Krug S.E., Alpert S.E., Marx C.M. Hospital Treatment of Asthma: Lack of Benefit from Theophylline Given in Addition to Nebulized Albuterol and Intravenously Administered Corticosteroid. J. Pediatr. 1993; 122: 464–469
   PubMed Web of Science ®Google Scholar
• Carter E., Cruz M., Chesrown S., Shieh G., Reilly K., Hendeles L. Efficacy of Intravenously Administered Theophylline in Children Hospitalized with Severe Asthma. J. Pediatr. 1993; 122: 470–476
   PubMed Web of Science ®Google Scholar
• Strauss R.E., Wertheim D.L., Bonguara V.R., Valacer D.J. Aminophylline Therapy Does Not Improve Outcome and Increases Adverse Effects in Children Hospitalized with Acute Asthmatic Exacerbations. Pediatrics 1994; 93: 205–210
   PubMed Web of Science ®Google Scholar
• Needleman J.P., Kaifer M.C., Nold J.T., Shuster P.E., Redding M.M., Gladstein J. Theophylline Does Not Shorten Hospital Stay for Children Admitted for Asthma. Arch. Pediatr. Adolesc. Med. 1995; 149: 206–209
   PubMedGoogle Scholar
• Bien J.P., Bloom M.D., Evans R.L., Specker B., O’Brien K.P. Intravenous Theophylline in Pediatric Status Asthmaticus. Clin. Ped. 1995; 34: 475–841
   PubMed Web of Science ®Google Scholar
• Nuhoglu Y., Dai A., Barlan I.B., Basaran M.M. Efficacy of Aminophylline in the Treatment of Acute Asthma Exacerbation in Children. Ann. Allergy Asthma Immunol. 1998; 80: 395–398
   PubMed Web of Science ®Google Scholar
• Siegel D., Sheppard D., Gelb A., Weinberg P.F. Aminophylline Increases the Toxicity But Not the Efficacy of an Inhaled Beta Adrenergic Agonist in the Treatment of Acute Exacerbations of Asthma. Am. Rev. Respir. Dis. 1985; 132: 283–286
   PubMed Web of Science ®Google Scholar
• Fanta C.H., Rossing T.H., McFadden E.R. Treatment of Acute Asthma: Is Combination Therapy with Sympathomimetics and Methylxanthines Indicated?. Am. J. Med. 1986; 80: 5–10
   PubMed Web of Science ®Google Scholar
• Yung M., South M. Randomised Controlled Trial of Aminophylline for Severe Acute Asthma. Arch. Dis. Child. 1998; 79: 405–410
   PubMed Web of Science ®Google Scholar
• Ream R.S., Loftis L.L., Albers G.M., Becker B.A., Lynch R.E., Mink R.B. Efficacy of IV Theophylline in Children with Severe Status Asthmaticus. Chest 2001; 119: 1480–1488
   PubMed Web of Science ®Google Scholar
• Zainudin B.M.Z., Ismail O., Yusoff K. Effect of Adding Aminophylline Infusion to Nebulised Salbutamol in Severe Acute Asthma. Thorax 1994; 49: 267–269
   Google Scholar
• Becker A.B., Nelson N.A., Simons F.E.R. The Pulmonary Index: Assessment of a Clinical Score for Asthma. Am. J. Dis. Child. 1984; 138: 574–576
   PubMedGoogle Scholar
• Pierson W.E., Bierman C.W., Stamm S.J., VanArsdel P.P. Double-Blind Trial of Aminophylline in Status Asthmaticus. Pediatrics 1971; 54: 282–288
   Google Scholar
• Huang D., O’Brien R.G., Harman E., Aull L., Reents S., Visser J., Shieh G., Hendeles L. Does Aminophylline Benefit Adults Admitted to the Hospital for an Acute Exacerbation of Asthma?. Ann. Intern. Med. 1993; 119: 1155–1160
   Google Scholar
• Weinberger M., Hendeles L. Theophylline in Asthma. N. Engl. J. Med. 1996; 334: 1380–1388
   PubMed Web of Science ®Google Scholar
• Bishop J., Carlin J., Nolan T. Evaluation of the Properties and Reliability of a Clinical Severity Scale for Acute Asthma in Children. J. Clin. Epidemiol. 1992; 45: 71–76
   PubMed Web of Science ®Google Scholar
• Wood D.W., Downes J.J., Lecks H.I. A Clinical Scoring System for the Diagnosis of Respiratory Failure. Am. J. Dis. Child. 1972; 123: 227–228
   PubMedGoogle Scholar
• Shannon M. Life-Threatening Events After Theophylline Overdose: A 10 Year Prospective Analysis. Arch. Intern. Med. 1999; 159: 989–994
   PubMed Web of Science ®Google Scholar
• Tsiu S.J., Self T.H., Burns R. Theophylline Toxicity: Update. Ann. Allergy 1990; 64: 241–257
   PubMedGoogle Scholar
• Self T.H., Chafin C.C., Soberman J.E. Effect of Disease States on Theophylline Serum Concentrations: Are We Still Vigilant?. Am. J. Med. Sci. 2000; 319: 177–182
   PubMed Web of Science ®Google Scholar
• Schiff G.D., Hegde H.K., LaCloche L., Hryhorczuk D.O. Inpatient Theophylline Toxicity: Preventable Factors. Ann. Intern. Med. 1991; 114: 748–753
   Google Scholar
• Sessler C.N. Theophylline Toxicity: Clinical Features of 115 Consecutive Cases. Am. J. Med. 1990; 88: 567–576
   PubMed Web of Science ®Google Scholar
• Hendeles L., Jenkins J., Temple R. Revised FDA Labeling Guideline for Theophylline Oral Dosage Forms. Pharmacotherapy 1995; 15: 409–427
   Google Scholar
• Expert Panel Report. Guidelines for the Diagnosis and Management of Asthma. NIH Publication No. 91-3042, National Institutes of Health, Bethesda 1991
   Google Scholar
• Fairshter R.D., Busse W.W. Theophylline—How Much Is Enough?. J. Allergy Clin. Immunol. 1986; 77: 646–648
   Google Scholar
• Self T.H., Heilker G.M., Alloway R.R., Kelso T.M., Abou-Shala N. Reassessing the Therapeutic Range for Theophylline on Laboratory Report Forms: The Importance of 5–15 mcg/mL. Pharmacotherapy 1993; 13: 590–549
   Google Scholar
• Schuh S., Johnson D.W., Callahan S., Canny G., Levison H. Efficacy of Frequent Nebulized Ipratropium Bromide Added to Frequent High Dose Albuterol Therapy in Severe Childhood Asthma. J. Pediatr. 1995; 126: 639–645
   PubMedGoogle Scholar
• Rowe B.H., Bretzlaff J.A., Bourdon C., Bota G.W., Camargo C.A. Intravenous Magnesium Sulfate Treatment for Acute Asthma in the Emergency Department: A Systematic Review of the Literature. Ann. Emerg. Med. 2000; 36: 181–190
   PubMed Web of Science ®Google Scholar
• Manthous C.A., Hall J.B., Caputa M.A., Walter J., Klocksieben J.M., Schmidt G.A., Wood L.O. Heliox Improves Pulsus Paradoxus and Peak Expiratory Flow in Nonintubated Patients with Severe Asthma. Am. J. Respir. Crit. Care Med. 1995; 151: 310–314
   PubMed Web of Science ®Google Scholar
• Kress J.P., Noth I., Gehlbach B.K., Barman N., Pohlman A.S., Miller A., Morgan S., Hall J.B. The Utility of Albuterol Nebulized with Heliox During Acute Asthma Exacerbations. Am. J. Respir. Crit. Care Med. 2002; 165: 1317–1321
   PubMed Web of Science ®Google Scholar
• Appel D., Karpel J.P., Sherman M. Epinephrine Improves Expiratory Flow Rates in Patients with Asthma Who Do Not Respond to Inhaled Metaproterenol Sulfate. J. Allergy Clin. Immunol. 1989; 84: 90–98
   Google Scholar